Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment […]
Washington [US], August 19 (ANI): A new study from Washington University School of Medicine in St. Louis has found a strong association between high levels of physical activity and the ability to maintain cognitive function among breast cancer patients treated with chemotherapy.
\
\
\
\
